Health care

Health care

AstraZeneca bresst cancer drug gets FDA approval

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) was approved in the US for the treatment of adult patients with a type of breast cancer.   Enhertu is a  HER2-directed antibody-drug conjugate (ADC) being jointly developed and commercialized by AstraZeneca and Daiichi Sankyo.   The approval by the Food and Drug Administration was based on the results from the DESTINY-Breast04 Phase III trial. Median overall...

Newark-area business recalls enhancement product that contains Viagra ingredient

Shopaax.com, based near Newark, voluntarily  recalled  the Kingdom Honey Royal Honey VIP sex enhancement product  due to the presence of Sildenafil, the active ingredient in the erectile dysfunction drug Viagra. The announcement was made by the U.S. Food and Drug Administration. The use of Viagra and generic equivalent is restricted to use under the supervision of licensed health care professionals. The use...

ChristianaCare gets high scores in annual U.S News ranking

ChristianaCare has been rated as a Best Hospital by U.S. News & World Report in its 2022-23 annual rankings.ChristianaCare was ranked No. 42 in the nation in obstetrics and gynecology. ChristianaCare also was ranked as high-performing in orthopedics.ChristianaCare was ranked the No. 1 hospital in Delaware and the No. 4 hospital in the Philadelphia region.U.S. News & World Report...

From WHYY: Northern Del. sewers provide a clearer view of Covid numbers

A sharp drop in clinical testing hasn’t stopped New Castle County from getting a clear picture of Covid-19 in Delaware’s most populous county. Since the early days of the pandemic, the county has turned to its sewers to identify patterns and predict Covid-positive cases. Scientists from all over the world began examining wastewater after discovering evidence that coronavirus infection can...

My take: New Crozer CEO faces challenges as ChristianaCare merger looms

My take: New Crozer CEO faces challenges as ChristianaCare merger looms The merger process of ChristianaCare and Delaware County's Crozer Health had been in a quiet phase. Then came news of Crozer getting a new CEO, the third in recent years. New CEO, Anthony Esposito, in a surprisingly candid interview with the Delco Times talked about the challenges of "stabilizing"  the...

Ground broken for Milton medical pavilion

Beebe Healthcare took part earlier this week in Phoenix RHCS Holdings’ groundbreaking event for the Jerry Ann McLamb Medical Pavilion near Milton.  Beebe Medical Group is planning a primary care, walk-in care, laboratory and diagnostic imaging for the Milton community and surrounding area from the pavilion. The pavilion is named in honor of Jerry Ann McLamb, a graduate...

Incyte gets FDA blessing for vitiligo pigment disease cream treatment

Delaware-based Incyte reported  that the U.S. Food and Drug Administration approved Opzelura (ruxolitinib) cream 1.5% for the topical treatment of nonsegmental vitiligo in adult and pediatric patients 12 years of age and older. Opzelura is the first FDA-approved treatment for repigmentation in patients with vitiligo, and the only topical formulation of a Janus kinase (JAK) inhibitor approved in the United States. Vitiligo is...

Delaware sees uptick in Covid cases

The Delaware Division of Public Health reported an uptick in Covid-19 cases. in its monthly report, with Sussex County in the "high category DPH continues to advise Delawareans to get booster shots. Delaware also exceeded 3,000 Covid-related deaths. According to the Centers for Disease Control and Prevention’s (CDC) COVID-19 Community Levels data tracker, last updated on June 14, case levels...

Covid-19 death toll in Delaware hits 3,000 mark

This week, deaths from Covid-19 moved past the 3,000 mark. Three deaths were reported from the virus on Tuesday and Wednesday, bringing the fatality toll to 3,001, according to the Delaware Division of Public Health. Ages ranged from their 60s to their 80s. One of the individuals had an underlying health condition. Their vaccination status was not listed. On...

ChristianaCare buys Jennersville Hospital site, offices, land for $8 million

ChristianaCare has completed its purchase of the former Jennersville Hospital in West Grove, PA from Tower Health for $8 million. The northern Delaware-based healthcare system will put a priority on reopening emergency services at the hospital site that will be known as ChristianaCare West Grove Campus. “It is our privilege to serve our neighbors in southern Chester County as...

Medicaid managed care program to add 3rd provider

The Department of Health and Social Services (DHSS) selected three companies to operate its Medicaid Managed Care Program. DHSS’ Division of Medicaid and Medical Assistance (DMMA) will continue its managed care partnership with Highmark Health Options Blue Cross Blue Shield, which began in 2015, and with AmeriHealth Caritas, which began in 2018. In addition, DHS announced plans to contract with Centene’s...

Delaware health officials report 1st probable case of monkeypox

The Delaware Division of Public Health confirmed he state’s first case of the monkeypox virus (MPX). This week, DPH received test results showing a 41-year-old New Castle County man tested positive for MPX. This positive case is considered probable pending confirmatory testing by the Centers for Disease Control and Prevention. The Delaware man did not report any travel or...

Crozer gets new CEO ahead of a possible merger with ChristianaCare

Crozer Health has announced leadership changes ahead of a possible merger with Delaware-based ChristianaCare, the Philadephia Business Journal reported. Anthony Esposito moved over to CEO from another management post with the Crozer system. He will be the third person to hold the position in recent months. His predecessor from Prospect, the pro-profit parent company of the health system took...

AstraZeneca acquires company with early-stage blood cancer drug candidate

AstraZeneca agreed to acquire TeneoTwo, Inc., including its clinical-stage CD19/CD3 T-cell engager, TNB-486 blood cancer drug. Anas Younes, senior vice president of Haematology R&D, at AstraZeneca said: “By redirecting the body’s natural immune response to target B-cell malignancies, TNB-486 alone or in combination with CD20-targeted therapy could potentially deepen clinical responses and improve patient outcomes. We believe this innovative...

House passes $1.4 billion Bond Bill as session winds down

The House on Tuesday approved a state-record $1.4 billion capital budget. House Bill 475 was hashed out by the Joint Bond Bill Committee, a 12-member panel of representatives and senators from both parties. The Bond Bill funds various construction, planning, and repair projects for state infrastructure, buildings, and grounds. The Bond Bill is a major contributor to the state's economy. ...